(jama1989;261) Trends in cigarette smoking in United States the changing influence of gender and race,

(2004) Women's susceptibility to tobacco carcinogens,

(1825-30) Female-male differences in patients with primary lung cancer,

(epidemiology1992;3) Gender and histologic type variations in smoking-related risk of lung cancer,

(1996) United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females,

(2002) Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival,

Sex differences in lung-cancer risk associated with cigarette smoking,

Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features,

(1998) Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioloalveolar cell carcinoma,

(1997) Cigarette smoking and changes in the histopathology of lung cancer,

(1995) Lung cancer pathology in smokers, ex-smokers and never smokers,

(2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer ,

(2000) Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma,

(2006) An epidemiologic study of early onset lung cancer,

Fu JB, (2005) Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database,

O'Connell JP, (jclinoncol1986;4) Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy,

Minami H, (2000) Lung cancer in women sex-associated differences in survival of patients undergoing resection for lung cancer,

Alexiou C, (2002) Do women live longer following lung resection for carcinoma? ,

Ferguson MK, (2000) Sex-associated differences in survival of patients undergoing resection for lung cancer,

Risch HA, (amjepidemiol1993;138) Are female smokers at higher risk for lung cancer than male smokers? A case control analysis by histologic type,

Kure EH, (1996) p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels,

Ryberg D, Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients,

Mollerup S, (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients,

Nelson HH, (1999) Implications and prognostic value of K-ras mutation for early-stage lung cancer in women,

Caracta CF, (1999) Estrogen receptor status of lung cancer cell lines ,

(1996) Preferential formation of benzo [] pyrene adducts at lung cancer mutational hotspots in p53,

(eurrespirj1994;71877-88) Exposure to environmental tobacco smoke and risk of lung cancer,

(1996) Familial risk of lung cancer among nonsmokers and their relatives,

Increased familial risk for lung cancer,

(2000) Chinese food cooking and lung cancer in women nonsmokers,

Epidemiology and etiology of lung cancer, Clin Chest Med 1993;14

(2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women,

(1999) Previous lung disease and risk of lung cancer among men and women nonsmokers,

(2002) Gender- dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue,

(2001) Expression, function, and clinical implications of estrogen receptor ß in human lung cancers,

Endocrine factors and adenocarcinoma of the lung in women,

(1996) Bronchioloalveolar carcinoma,

(2002) A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer,

(2000) Evaluation of HER-2/neu expression on lung tumors by immunohistochemistry and fluorescence in situ hybridization ,

(1995) Expression and activation of erb-2 and epidermal growth factor receptor in lung adenocarcinomas,

(2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk,

(2003) Genetic susceptibility to lung cancer the role of DNA damage and repair,

(2002) Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer,

(2000) Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small cell lung cancer (LA-NSCLC): identification of five groups with different survival,

(jclinoncol1991;9) Survival determinants in extensive-stage non-small cell lung cancer,